Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Immunohistochemistry Assay, Antibody, MET

Número de PMA: P240037 · 2025-07-11

SolicitanteVentana Medical Systems, Inc. (Roche Tissue Diagnostics)
Fecha de decisión2025-07-11
Número PMAP240037
Código de productoSER
Clase del dispositivoClase 3
Especialidad médicaH
Número de regulación21 CFR 8
Comité asesorPA

Resumen del dispositivo

Immunohistochemistry Assay, Antibody, MET is the device name listed in this FDA 510(k) record. The listed applicant is Ventana Medical Systems, Inc. (Roche Tissue Diagnostics). It received FDA 510(k) clearance on 2025-07-11. The device is classified under product code SER. It was reviewed by the PA advisory panel.

Preguntas frecuentes

What is the Immunohistochemistry Assay, Antibody, MET?

Immunohistochemistry Assay, Antibody, MET is a medical device that received FDA 510(k) clearance on 2025-07-11. The listed applicant is Ventana Medical Systems, Inc. (Roche Tissue Diagnostics).

When did Immunohistochemistry Assay, Antibody, MET receive FDA 510(k) clearance?

The clearance date for Immunohistochemistry Assay, Antibody, MET can be found in the official FDA records.

Who is the listed applicant for Immunohistochemistry Assay, Antibody, MET?

The FDA 510(k) record lists Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Immunohistochemistry Assay, Antibody, MET?

The FDA product code for Immunohistochemistry Assay, Antibody, MET is SER.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑